Wagner Lisa, Lacey Margaret D
Clin J Oncol Nurs. 2004 Jun;8(3):279-87. doi: 10.1188/04.CJON.279-287.
Since the 1970s, remarkable advances have been made in the early diagnosis, treatment, and survival rates of patients with cancer. This has coincided with rapid changes in the healthcare industry. As cancer has been transformed into a chronic disease that generally is treated in the outpatient setting, the financial burden on patients with cancer and their families has grown. Insurance premiums, deductibles, copayments, transportation, lost income, and miscellaneous out-of-pocket expenses are just some of the hidden, nonreimbursable costs that significantly affect the financial stability of families over time. In addition, certain populations are at greater risk of financial burden, which may affect compliance with treatment as well as patient outcomes. This article presents an overview of these hidden costs, with implications and referral resources for oncology nurses. Healthcare providers have a responsibility to assess their patients for financial need and assist them in accessing resources.
自20世纪70年代以来,癌症患者的早期诊断、治疗及生存率都取得了显著进展。这与医疗行业的快速变革同步。随着癌症已转变为一种通常在门诊环境中治疗的慢性病,癌症患者及其家庭的经济负担日益加重。保险费、免赔额、共付额、交通费用、收入损失以及其他自付费用,只是一些长期显著影响家庭财务稳定的隐性、不可报销费用。此外,某些人群面临的经济负担风险更大,这可能会影响治疗依从性以及患者的治疗结果。本文概述了这些隐性成本,并为肿瘤护理人员提供了相关影响及转诊资源。医疗服务提供者有责任评估患者的经济需求,并协助他们获取资源。